Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ryvu | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 713.26M | -6.1x | 0.24 | PLN 30.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Selvita | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 585.54M | -122.1x | 1.11 | PLN 32.30 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Scope Fluidics | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 433.42M | 7.1x | 0.02 | PLN 159 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.2% Upside | Upgrade to Pro+ | |
Bioton SA | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 354.62M | -21.6x | 0.04 | PLN 4.17 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Captor Therapeutics | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 229.99M | -3.9x | -0.14 | PLN 41.70 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mabion | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 153.06M | -3.9x | 0.02 | PLN 9.47 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.5% Downside | Upgrade to Pro+ | |
Poltreg | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 152.03M | -7.8x | 0.22 | PLN 32.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Molecure | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 118.39M | -4.2x | -0.25 | PLN 5.86 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomtec | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 105.11M | -9.1x | 1.98 | PLN 6.63 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanogroup | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 83.20M | -16x | -0.27 | PLN 2.63 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyenergy | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 78.58M | 38.2x | 0.36 | PLN 2.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Urteste | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 69.07M | -24.3x | -0.49 | PLN 47.90 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Readgene | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 60.84M | -101x | -1.81 | PLN 5.16 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sds Optic | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 41.30M | PLN 6.96 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Sygnis | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 35.09M | PLN 1.47 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Genomed | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 34.09M | 17.4x | 0.05 | PLN 25.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicofarma Biotech | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 18.35M | -6.1x | 1.43 | PLN 0.27 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stem Cells Spin | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 12.32M | -23.5x | 0.16 | PLN 0.30 | -7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |